NEUROCRINE

Company

NEUROCRINE BIOSCIENCES INC

Filed

February 8, 2005

Accession Number

0000912938-05-000234

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →